Multisectoral actions of mental health during the COVID‐19 pandemic in Mazandaran province of Iran

Abstract

Aim: A widespread outbreak of COVID-19 is followed by adverse effects on the mental health of the general population. Therefore, this study is an audit to investigate the activities of various organizations during the COVID-19 pandemic in Mazandaran Province, Iran. Methods:The aim of the study was to collect the data, the relevant officials in various organizations and units were contacted to collect the statistics of actions taken in psychology and psychiatry wards. Moreover, databases such as Google Scholar and Iranian resources were searched.Results: According to the results, different healthcare systems worked in parallel during the peak of the COVID-19 pandemic. For example, Mazandaran University of Medical Science [MAZUMS] Health Vice-Chancellor performed the following activities during this crisis: establishing a virtual crisis management working group, holding a provincial educational committee to train the crisis management teams, organizing virtual psychological intervention teams in the healthcare systems, and so forth. In addition, the mental health activities by Mazandaran Welfare Organization duringThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Frequency of delirium and its associated factors among COVID‐19 inpatients in Iran

“…As an unprecedented global health threat, 1,2 the coronavirus disease 2019 (COVID- 19) pandemic is affecting all people worldwide, regardless of their age, nationality or socioeconomic status. Nevertheless, older adults are at greater risk of developing respiratory, cardiovascular and brain complications after contracting this infection.…”

“…The factors that are likely to be connected with delirium in COVID‐19 patients consist of social and epidemiological factors (e.g. social distancing and quarantine and increased occupational workload of healthcare providers), iatrogenic factors (such as the excessive use of sedatives to facilitate mechanical ventilation (MV), 2 prolonged MV, lengthened immobility, inadequate pain evaluation and alleviation and delayed weaning due to fear of aerosol spread) and psychological ones (viz. fear of death, loneliness, fear of global pandemic, anxiety, future uncertainty, loss of awareness of time and place, lack of religious/spiritual support, hallucination, delusion and sleep disorders) 3,11 .…”

Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non‐critical COVID‐19 pneumonia: A double‐blind randomized, placebo‐controlled clinical trial

“…The coronavirus disease 2019 (COVID‐19) was primarily detected in the city of Wuhan, China, and then became an ongoing pandemic 1,2 . Clinical manifestations of coronavirus‐acute respiratory syndrome‐2 (SARS‐COV‐2) disease range from asymptomatic cases to severe pneumonia and acute respiratory distress syndrome that require intensive care 3,4 .…”

“…The coronavirus disease 2019 (COVID- 19) was primarily detected in the city of Wuhan, China, and then became an ongoing pandemic. 1,2 Clinical manifestations of coronavirus-acute respiratory syndrome-2 (SARS-COV-2) disease range from asymptomatic cases to severe pneumonia and acute respiratory distress syndrome that require intensive care. 3,4 Very limited treatment options for COVID-19 management have made vital the urgent need to identify safe, effective and globally available drugs to control the disease.…”